resveratrol has been researched along with Cancer of Esophagus in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (50.00) | 29.6817 |
| 2010's | 3 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chiu, JF; Hasenmayer, D; Li, G; Tang, Q; Wei, X; Zhang, D; Zhang, H; Zhang, J | 1 |
| Cheng, HY; Fan, GH; Ma, JX; Qin, Q; Sun, XC; Wang, ZM; Xu, LP; Yang, X; Zhang, C | 1 |
| Lagergren, J; Lin, Y; Lu, Y; Yngve, A | 1 |
| Li, Y; Liu, QH; Martin, RC; Wo, J; Woodall, CE | 1 |
| Ding, Y; Hashimoto, Y; Hong, T; Imamura, M; Kaganoi, J; Kawabe, A; Komoto, I; Li, ZG; Shimada, Y | 1 |
| Sun, YN; Yan, Y; Zhou, HB; Zhu, JR | 1 |
6 other study(ies) available for resveratrol and Cancer of Esophagus
| Article | Year |
|---|---|
Resveratrol-induced apoptosis is enhanced by inhibition of autophagy in esophageal squamous cell carcinoma.
Topics: Apoptosis; Autophagy; Carcinoma, Squamous Cell; Cell Line, Tumor; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Humans; K562 Cells; Microscopy, Electron, Transmission; Resveratrol; Stilbenes | 2013 |
Resveratrol inhibits oesophageal adenocarcinoma cell proliferation via AMP-activated protein kinase signaling.
Topics: Adenocarcinoma; AMP-Activated Protein Kinases; Anticarcinogenic Agents; Apoptosis; Blotting, Western; Cell Proliferation; Cyclin-Dependent Kinase Inhibitor p57; Esophageal Neoplasms; Humans; Proteasome Endopeptidase Complex; Real-Time Polymerase Chain Reaction; Resveratrol; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; RNA, Small Interfering; S-Phase Kinase-Associated Proteins; Signal Transduction; Stilbenes; Tumor Cells, Cultured; Ubiquitination | 2014 |
A dietary pattern rich in lignans, quercetin and resveratrol decreases the risk of oesophageal cancer.
Topics: Adenocarcinoma; Aged; Anticarcinogenic Agents; Antineoplastic Agents, Phytogenic; Carcinoma, Squamous Cell; Case-Control Studies; Diet; Esophageal Neoplasms; Esophagus; Feeding Behavior; Female; Humans; Lignans; Logistic Models; Male; Middle Aged; Odds Ratio; Plant Extracts; Quercetin; Resveratrol; Stilbenes | 2014 |
Chemoprevention of metaplasia initiation and carcinogenic progression to esophageal adenocarcinoma by resveratrol supplementation.
Topics: Animals; Anticarcinogenic Agents; Apoptosis; Catalase; Disease Models, Animal; Disease Progression; Esophageal Neoplasms; Esophagus; Glutathione; Immunohistochemistry; In Situ Nick-End Labeling; Male; Metaplasia; Oxidative Stress; Rats; Rats, Sprague-Dawley; Resveratrol; Stilbenes; Superoxide Dismutase; Thiobarbituric Acid Reactive Substances | 2009 |
Suppression of N-nitrosomethylbenzylamine (NMBA)-induced esophageal tumorigenesis in F344 rats by resveratrol.
Topics: Animals; Carcinogenicity Tests; Cyclooxygenase 1; Cyclooxygenase 2; Dimethylnitrosamine; Dinoprostone; Disease Models, Animal; Esophageal Neoplasms; Isoenzymes; Male; Membrane Proteins; Prostaglandin-Endoperoxide Synthases; Rats; Rats, Inbred F344; Resveratrol; RNA, Messenger; Stilbenes; Transcription, Genetic | 2002 |
Resveratrol induces apoptosis in human esophageal carcinoma cells.
Topics: Antineoplastic Agents, Phytogenic; Apoptosis; Carcinoma; Esophageal Neoplasms; Humans; Resveratrol; Stilbenes; Tumor Cells, Cultured | 2003 |